Pliant Therapeutics (PLRX) Total Non-Current Liabilities (2019 - 2021)

Pliant Therapeutics (PLRX) has 3 years of Total Non-Current Liabilities data on file, last reported at $22.2 million in Q4 2021.

• Total Non-Current Liabilities for Q4 2021 came in at $22.2 million, up 91.02% year-over-year; the trailing twelve-month figure through Dec 2021 was $22.2 million (up 91.02% YoY), and the FY2021 annual result was $22.2 million, up 91.02% from the prior year.
• Total Non-Current Liabilities rose to $22.2 million in Q4 2021 per PLRX's latest filing, from $12.9 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $22.2 million in Q4 2021 and troughed at $8.6 million in Q4 2019.
• A 3-year average of $12.5 million and a median of $11.6 million in 2020 frame the typical range for Total Non-Current Liabilities.
• On a YoY basis, Total Non-Current Liabilities climbed as much as 91.02% in 2021 and fell as far as 9.17% in 2021.
• A 3-year view of Total Non-Current Liabilities shows it stood at $8.6 million in 2019, then jumped by 34.25% to $11.6 million in 2020, then jumped by 91.02% to $22.2 million in 2021.
• Business Quant data shows PLRX's Total Non-Current Liabilities at $22.2 million in Q4 2021, $12.9 million in Q3 2021, and $10.9 million in Q2 2021.